MORGAN STANLEY - 31 Dec 2024 SCHEDULE 13G/A Report for UroGen Pharma Ltd. Ordinary Shares (URGN)

Filing Manager
MORGAN STANLEY
Reporting Manager
Morgan Stanley
Symbol
URGN
Shares outstanding
41.8M shares
Disclosed Ownership
753K shares
Ownership
1.8%
Form type
SCHEDULE 13G/A
Filing time
05 Feb 2025, 10:09:20 UTC
Date of event
31 Dec 2024
Next filing
06 Aug 2025

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Morgan Stanley 1.8% 753K 0 748K Christopher O'Hara Authorized Signatory, Morgan Stanley